Lysergic Acid Diethylamide (LSD) Antikörper
Kurzübersicht für Lysergic Acid Diethylamide (LSD) Antikörper (ABIN1001367)
Target
Alle Lysergic Acid Diethylamide (LSD) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Lysergic Acid Diethylamide/Nor-Lysergic Acid Diethylamide (LSD)
-
Aufreinigung
- Salt fractionation.
-
Immunogen
- LSD-BSA
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Application_Dilutions: 1/500
Tested_Applications: The antibody is suitable for the development of immunoassays or immunoaffinity purification columns.
-
Kommentare
-
10 ng/mL LSD produces 91 % inhibition in a competitive ELISA employing Lysergic Acid Diethylamide/Nor-Lysergic Acid Diethylamide (LSD) polyclonal antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 20 mM Phosphate, 150 mM Sodium Chloride. pH 7.4, 0.09 % Sodium Azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Can be stored for up to 3 months at +2°C - +8°C. For long term storage, aliquot and store at ≤-20 °C. Avoid repeated freeze/thaw cycles. Product should be protected from light exposure.
-
-
- Lysergic Acid Diethylamide (LSD)
-
Andere Bezeichnung
- LSD
-
Substanzklasse
- Chemical
-
Hintergrund
- Lysergic acid diethylamide (LSD) is a highly potent hallucinogenic drug. It was first synthesized in 1938 from lysergic acid which was derived from ergot, a fungus found growing wild on rye and other grasses.
Target
-